Founder & CEO at Loyal
I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.
We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.
As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.
I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.
I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.
Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.
It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.
We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.
Founder & CEO at Loyal
I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.
We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.
As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.
I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.
I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.
Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.
It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.
We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.
By using this service, you agree to the Terms of Service and Privacy Policy.